Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$980M |
| 2 |
Newmont
NEM
|
+$415M |
| 3 |
Moody's
MCO
|
+$313M |
| 4 |
Uber
UBER
|
+$263M |
| 5 |
AbbVie
ABBV
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$981M |
| 2 |
Microsoft
MSFT
|
+$876M |
| 3 |
HES
Hess
HES
|
+$530M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$438M |
| 5 |
Merck
MRK
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.3% |
| 2 | Healthcare | 12.26% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.97B
| $200K | ﹤0.01% |
+2,645
| New | +$186K |
|
|
LENZ
3827
LENZ Therapeutics
LENZ
$145M
| $199K | ﹤0.01% |
10,865
-442
| -4% | -$7.3K |
|
3828
Mama's Creations
MAMA
$790M
| $198K | ﹤0.01% |
40,366
+26,846
| +199% | +$106K |
|
|
GORV
3829
DELISTED
Lazydays
GORV
| $197K | ﹤0.01% |
933
-984
| -51% | -$205K |
|
3830
Eagle Bancorp Montana
EBMT
$189M
| $197K | ﹤0.01% |
12,472
-9,959
| -44% | -$125K |
|
3831
OP Bancorp
OPBK
$235M
| $196K | ﹤0.01% |
17,913
-40,220
| -69% | -$369K |
|
3832
National CineMedia
NCMI
$252M
| $195K | ﹤0.01% |
47,175
| – | – |
|
|
NBH
3833
Neuberger Municipal Fund Inc
NBH
$304M
| $195K | ﹤0.01% |
+18,818
| New | +$181K |
|
|
ESPR
3834
DELISTED
Esperion Therapeutics
ESPR
| $195K | ﹤0.01% |
65,134
+37,738
| +138% | +$49K |
|
|
CODX
3835
Co-Diagnostics
CODX
$5.49M
| $194K | ﹤0.01% |
4,854
| – | – |
|
3836
Zura Bio
ZURA
$540M
| $193K | ﹤0.01% |
41,407
+7,434
| +22% | +$37.2K |
|
3837
Zedge
ZDGE
$38.9M
| $193K | ﹤0.01% |
81,934
| – | – |
|
|
PRPH
3838
DELISTED
ProPhase Labs
PRPH
| $192K | ﹤0.01% |
4,253
-2,087
| -33% | -$95.1K |
|
3839
NLI Holdings
NL
$319M
| $192K | ﹤0.01% |
34,167
-140,647
| -80% | -$705K |
|
3840
Lexeo Therapeutics
LXEO
$407M
| $189K | ﹤0.01% |
+14,110
| New | +$175K |
|
3841
CALL
Carnival Corporation Ltd
CCL
$38.9B
| $185K | ﹤0.01% |
10,000
| – | – |
|
3842
Adicet Bio
ACET
$77.3M
| $184K | ﹤0.01% |
6,096
-2,116
| -26% | -$46.1K |
|
|
AKTS
3843
DELISTED
Akoustis Technologies Inc
AKTS
| $184K | ﹤0.01% |
220,393
| – | – |
|
3844
Blend Labs
BLND
$367M
| $182K | ﹤0.01% |
71,423
+894
| +1% | +$1.35K |
|
3845
Nuveen Municipal Value Fund
NUV
$1.9B
| $182K | ﹤0.01% |
21,128
-30,252
| -59% | -$252K |
|
3846
OPAL Fuels
OPAL
$67.7M
| $181K | ﹤0.01% |
32,753
+17,516
| +115% | +$108K |
|
3847
MediciNova
MNOV
$64.5M
| $180K | ﹤0.01% |
119,894
-99
| -0.1% | -$179 |
|
3848
Trevi Therapeutics
TRVI
$2.59B
| $179K | ﹤0.01% |
133,381
-699
| -0.5% | -$1.06K |
|
3849
Veritone
VERI
$139M
| $179K | ﹤0.01% |
98,739
-129,526
| -57% | -$289K |
|
|
SWKH
3850
DELISTED
SWK Holdings
SWKH
| $177K | ﹤0.01% |
12,731
-177
| -1% | -$2.31K |
|
Similar funds
Bank of New York Mellon's Q4 2023 Portfolio in Review
As of Q4 2023, Bank of New York Mellon held 4,468 positions worth $493B, up 8.4% from $455B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q4 2023 filing shows 126 new, 1,615 increased, 2,238 reduced and 158 closed positions. Its largest new stake was Veralto: 3,360,679 shares worth $276M. The largest sale was Apple, an estimated $981M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2023 buy was Veralto: 3,360,679 shares worth $276M.
- Bank of New York Mellon added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $980M increase.
- Bank of New York Mellon's biggest Q4 2023 reduction was Apple, cutting an estimated $981M.
- Bank of New York Mellon fully exited Activision Blizzard in Q4 2023, selling an estimated $438M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $493B portfolio in Q4 2023.
- Bank of New York Mellon opened 126 new positions and closed 158 in Q4 2023.
- Bank of New York Mellon's portfolio value rose 8.4% quarter-over-quarter to $493B.
Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.